IMVT   $29.47  -0.47% Market Open

Immunovant Inc
Last Events:

2023-09-26 The hottest instrument.

2023-08-09 Signal in EMA20 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-06 Signal in Stochastic changed from bearish reversal to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-08-05 Signal in Stochastic changed from bullish to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.

2023-08-04 Signal in MACD changed from bullish recovery to bullish weakening. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

2023-08-04 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

2023-08-02 Signal in Stochastic changed from bullish reversal to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

2023-07-30 Signal in Stochastic changed from bearish weakening to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: exit from the oversold zone.


Current temperature: 11.53
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 13
Target Price Mean 49.31
Mean unverified/preliminary 49.31 / 49.31
Target Price Low / High 41.00 / 60.00
Median / STD DEV 49.00 / 5.20
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell None
macd Sell None None
stoch Sell None None
ma20 Sell Sell Sell
ma50 Sell None None
ma100 Sell ActivelyBuy Sell
Candlestick PatternSept. 16, 2024 Bullish Ladder - is a made up of five candlesticks. Pattern appears on a downtrend. Three strong black candlesticks follows by the fourth black candlestick closes also lower but has a long upper shadow. The fifth day is a strong white with an open above the previous day’s body. Considered to be a bullish reversal pattern.
ISIN US45258J1025
ceo Dr. Peter Salzmann M.B.A., M.D.
Website https://immunovant.com
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.